DOCSLIB.ORG

Code Procedure Cpt Price University Physicians Group

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Code Procedure Cpt Price University Physicians Group UNIVERSITY PHYSICIANS GROUP (UPG) PRICES OF PROVIDER SERVICES CODE PROCEDURE MOD CPT PRICE 0001A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 1ST DOSE 0001A $40.00 0002A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 2ND DOSE 0002A $40.00 0011A IMM ADMN SARSCOV2 100 MCG/0.5 ML 1ST DOSE 0011A $40.00 0012A IMM ADMN SARSCOV2 100 MCG/0.5 ML 2ND DOSE 0012A $40.00 0021A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 1ST DOSE 0021A $40.00 0022A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 2ND DOSE 0022A $40.00 0031A IMM ADMN SARSCOV2 AD26 5X10^10 VP/0.5 ML 1 DOSE 0031A $40.00 0042T CEREBRAL PERFUS ANALYSIS, CT W/CONTRAST 0042T $954.00 0054T BONE SURGERY USING COMPUTER ASSIST, FLURO GUIDED 0054T $640.00 0055T BONE SURGERY USING COMPUTER ASSIST, CT/ MRI GUIDED 0055T $1,188.00 0071T U/S LEIOMYOMATA ABLATE <200 CC 0071T $2,500.00 0075T 0075T PR TCAT PLMT XTRC VRT CRTD STENT RS&I PRQ 1ST VSL 26 26 $2,208.00 0126T CAROTID INT-MEDIA THICKNESS EVAL FOR ATHERSCLER 0126T $55.00 0159T 0159T COMPUTER AIDED BREAST MRI 26 26 $314.00 PR RECTAL TUMOR EXCISION, TRANSANAL ENDOSCOPIC 0184T MICROSURGICAL, FULL THICK 0184T $2,315.00 0191T PR ANT SEGMENT INSERTION DRAINAGE W/O RESERVOIR INT 0191T $2,396.00 01967 ANESTH, NEURAXIAL LABOR, PLAN VAG DEL 01967 $2,500.00 01996 PR DAILY MGMT,EPIDUR/SUBARACH CONT DRUG ADM 01996 $285.00 PR PERQ SAC AGMNTJ UNI W/WO BALO/MCHNL DEV 1/> 0200T NDL 0200T $5,106.00 PR PERQ SAC AGMNTJ BI W/WO BALO/MCHNL DEV 2/> 0201T NDLS 0201T $9,446.00 PR INJECT PLATELET RICH PLASMA W/IMG 0232T HARVEST/PREPARATOIN 0232T $1,509.00 0234T PR TRANSLUMINAL PERIPHERAL ATHERECTOMY, RENAL ARTERY 0234T $2,012.00 PR TRANSLUMINAL PERIPHERAL ATHERECTOMY, 0237T BRACHIOCEPHAL AND BRANCHES, EACH 0237T $1,868.00 PR TRANSLUMINAL PERIPHERAL ATHERECTOMY, ILIAC ARTERY, 0238T EACH 0238T $1,877.00 0253T PR INSERT ANT SGM DRAINAGE DEV W/O RESERVR INT APPR 0253T $2,584.00 0254T PR EVASC RPR ILAC ART BIFUR ENDGRFT CATHJ RS&I UNI 0254T $3,412.00 0275T PR PERC LAMINO-/LAMINECTOMY INDIR IMAG GUIDE LUMBAR 0275T $1,459.00 0281T PR PERC TRANSCTH CLOSR LT ATRIAL APPNDGE IMPLNT S&I 0281T $3,574.00 0296T PR EXT ECG > 48HR TO 21 DAY RCRD W/CONECT INTL RCRD 0296T $135.00 0298T PR EXT ECG > 48HR TO 21 DAY REVIEW AND INTERPRETATN 0298T $140.00 0346T PR ULTRASOUND ELASTOGRAPHY 0346T $276.00 0375T PR TOTAL DISC ARTHRP ANT APPR W/DISCECTOMY CRV 3+ 0375T $8,709.00 0376T PR ANT SEGMENT INSERT DRAIN W/O RESERVOIR EA ADDL 0376T $2,568.00 0379T PR VISUAL FIELD ASSESSMENT TECH SUPPORT W/INSTRUCT 0379T $109.00 0387T PR TRANSCATH INSERT OR REPLACE LEADLESS PM VENTR 0387T $1,124.00 0389T PR PROG DEVICE EVAL IN PERSON LEADLESS PM SYSTEM 0389T $115.00 0389T 0389T PR PROG DEVICE EVAL IN PERSON LEADLESS PM SYSTEM 26 26 $115.00 0391T PR INTERROG DEVICE EVAL IN PERSON LEADLESS PM SYST 0391T $87.00 0397T PR ERCP WITH OPTICAL ENDOMICROSCOPY ADD ON 0397T $1,002.00 $15,604.0 0398T PR MRGFUS STEREOTACTIC ABLATION LESION INTRACRANIAL 0398T 0 0399T PR MYOCARDIAL STRAIN IMAGING QUAN ASSMT 0399T $513.00 0399T 0399T PR MYOCARDIAL STRAIN IMAGING QUAN ASSMT 26 26 $513.00 0438T PR TPRNL PLMT BIODEGRADABLE MATRL PERIPROSTATIC 0438T $764.00 0442T PR ABLTJ PERC CRYOABLTJ IMG GDN NRV PLEX/TRNCL NRV 0442T $450.00 0449T PR INSJ AQUEOUS DRAIN DEV W/O EO RSVR INITIAL DEV 0449T $2,222.00 0466T PR INSRT CH WALL RESPIR ELTRD/RA & CONJ PULSE GEN 0466T $1,235.00 0474T PR CYPASS GLAUCOMA IMPLANT 0474T $3,333.00 0482T 0482T PR ABSOLUTE QUAN MYOCARD BLD FLO PET STRESS & REST 26 26 $179.00 0483T PR TMVI W/PROSTHETIC VALVE PERCUTANEOUS APPROACH 0483T $5,681.00 0484T PR TMVI W/PROSTHETIC VALVE TRANSTHORACIC EXPOSURE 0484T $8,059.00 0494T PR PREP & CANNULJ CDVR DON LNG ORGN PRFUJ SYS 0494T $812.00 0495T PR INIT & MNTR CDVR DON LNG ORGN PRFUJ SYS 1ST 2 HR 0495T $7,000.00 0496T PR MNTR CDVR DON LNG ORGN PRFUJ SYS EA ADDL HR 0496T $3,500.00 0497T PR XTRNL PT ACT ECG W/O ATTN MNTR IN-OFFICE CONN 0497T $24.00 0498T PR XTRNL PT ACT ECG W/O ATTN MNTR R&I PR 30 DAYS 0498T $65.00 0499T PR CYSTO W/DIL & URTL RX DEL F/URTL STRIX/STENOSIS 0499T $1,024.00 0504T PR COR FFR CTA DATA REVIEW W/INTERPJ & FINAL REPORT 0504T $443.00 0507T 0507T PR NEAR INFRARED DUAL IMG MEIBOMIAN GLND UNI/BI I&R 26 26 $16.00 0514T PR INTRAOPERATIVE VISUAL AXIS ID USING PT FIXATION 0514T $184.00 0537T PR CAR-T THERAPY HRVG BLD DRV T LMPHCYT PR DAY 0537T $220.00 0540T PR CAR-T THERAPY AUTOLOGOUS CELL ADMINISTRATION 0540T $500.00 0545T PR TCAT TV ANN RCNSTJ W/IMPL ADJST ANN RCNSTJ DEV 0545T $7,329.00 0569T PR TTVR PERCUTANEOUS APPROACH INITIAL PROSTHESIS 0569T $5,396.00 0570T PR TTVR PERCUTANEOUS APPROACH EACH ADDL PROSTHESIS 0570T $1,242.00 0570T 0570T PR TTVR PERCUTANEOUS APPROACH EACH ADDL PROSTHESIS 26 26 $635.00 0571T PR INSJ/RPLCMT ICDS W/SUBSTERNAL ELECTRODE 0571T $1,581.00 0572T PR INSJ SUBSTERNAL IMPLANTABLE DEFIBRILLATOR ELTRD 0572T $1,258.00 0573T PR RMVL SUBSTERNAL IMPLANTABLE DEFIBRILLATOR ELTRD 0573T $1,058.00 0574T PR REPOS PREV IMPL SS IMPLTBL DFB PACING ELTRD 0574T $1,039.00 0581T PR ABLATION MAL BRST TUMOR PERQ CRTX UNILATERAL 0581T $763.00 0584T PR PERCUTANEOUS ISLET CELL TRANSPLANT 0584T $5,361.00 0585T PR LAPAROSCOPIC ISLET CELL TRANSPLANT 0585T $2,451.00 0586T PR OPEN ISLET CELL TRANSPLANT 0586T $4,045.00 0589T PR ELEC ALYS SMPL PRGRMG IINS PTN 1-3 PARAMETERS 0589T $129.00 0590T PR ELEC ALYS CPLX PRGRMG IINS PTN 4+ PARAMETERS 0590T $300.00 0600T PR IRE ABLATION 1+TUMORS PER ORGAN W/IMG GDN PERQ 0600T $2,386.00 10004 PR FINE NEEDLE ASPIRATION BX W/O IMG GDN EA ADDL 10004 $135.00 10005 PR FINE NEEDLE ASPIRATION BX W/US GDN 1ST LESION 10005 $342.00 10006 PR FINE NEEDLE ASPIRATION BX W/US GDN EA ADDL 10006 $155.00 10007 PR FINE NEEDLE ASPIRATION BX W/FLUOR GDN 1ST LESION 10007 $729.00 10008 PR FINE NEEDLE ASPIRATION BX W/FLUOR GDN EA ADDL 10008 $411.00 10009 PR FINE NEEDLE ASPIRATION BX W/CT GDN 1ST LESION 10009 $1,193.00 10010 PR FINE NEEDLE ASPIRATION BX W/CT GDN EA ADDL 10010 $719.00 10011 PR FINE NEEDLE ASPIRATION BX W/MR GDN 1ST LESION 10011 $1,193.00 10012 PR FINE NEEDLE ASPIRATION BX W/MR GDN EA ADDL 10012 $719.00 10021 PR FINE NEEDLE ASP;W/O IMAGING GUIDANCE 10021 $357.00 10022 PR FINE NEEDLE ASP;W/IMAGING GUIDANCE 10022 $328.00 10030 PR IMAGE-GUIDED CATHETER FLUID COLLECTION DRAINAGE 10030 $1,938.00 10035 PR PERQ SFT TISS LOC DEVICE PLMT 1ST LES W/GDNCE 10035 $1,359.00 10040 PR ACNE SURGERY OF SKIN ABSCESS 10040 $276.82 10060 PR DRAIN SKIN ABSCESS SIMPLE 10060 $321.00 10061 PR DRAIN SKIN ABSCESS COMPLIC 10061 $556.00 10080 PR DRAIN PILONIDAL CYST SIMPL 10080 $558.00 10081 PR DRAIN PILONIDAL CYST COMPLIC 10081 $808.00 10120 PR REMOVE FOREIGN BODY SIMPLE 10120 $402.00 10121 PR REMOVE FOREIGN BODY COMPLIC 10121 $723.00 10140 PR DRAINAGE OF HEMATOMA/FLUID 10140 $452.00 10160 PR PUNCTURE DRAINAGE OF LESION 10160 $346.00 10180 PR COMPLEX DRAINAGE, WOUND 10180 $680.00 11000 PR DEBRIDEMENT, INFECTED SKIN, UP TO 10% BSA 11000 $150.00 11001 PR DEBRIDEMENT, INFECTED SKIN, EA ADD 10% BSA 11001 $63.00 11004 PR DEBRIDE NECROTIC SKIN/ TISSUE, GENIT & PERINM 11004 $1,554.00 11005 PR DEBRIDE NECROTIC SKIN/ TISSUE, ABD WALL 11005 $2,810.00 11006 PR DEBRIDE NECROT SKIN/ TISS, GENIT,PERI, ADB WALL 11006 $2,540.00 11008 REMOVE MESH FROM ABD WALL FOR INFECTION 11008 $745.00 11010 PR DEBRIDE ASSOC OPEN FX/DISLOC SKIN/SUBQ 11010 $1,412.00 11011 PR DEBRIDE ASSOC OPEN FX/DISLOC SKIN/MUSCLE 11011 $1,676.00 11012 PR DEBRIDE ASSOC OPEN FX/DISLO SKIN/MUS/BONE 11012 $2,446.00 11042 PR DEBRIDEMENT, SKIN, SUB-Q TISSUE,=<20 SQ CM 11042 $395.00 11043 PR DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,=<20 SQ CM 11043 $619.00 PR DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,BONE,=<20 SQ 11044 CM 11044 $981.00 11045 PR DEBRIDEMENT, SKIN, SUB-Q TISSUE,EACH ADD 20 SQ CM 11045 $111.00 PR DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,EACH ADD 20 11046 SQ CM 11046 $198.00 PR DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,BONE,EACH 11047 ADD 20 SQ CM 11047 $329.00 11055 PR TRIM HYPERKERATOTIC SKIN LESION, ONE 11055 $166.00 11056 TRIM BENIGN HYPERKERATOTIC SKIN LESION,2-4 11056 $187.09 11057 TRIM BENIGN HYPERKERATOTIC SKIN LESION,>4 11057 $226.00 11100 PR BIOPSY OF SKIN LESION 11100 $239.00 11101 PR BIOPSY, EACH ADDED LESION 11101 $74.00 11102 PR TANGENTIAL BIOPSY SKIN SINGLE LESION 11102 $265.00 11103 PR TANGENTIAL BIOPSY SKIN EA SEP/ADDITIONAL LESION 11103 $141.00 11104 PR PUNCH BIOPSY SKIN SINGLE LESION 11104 $333.00 11105 PR PUNCH BIOPSY SKIN EA SEP/ADDITIONAL LESION 11105 $161.00 11106 PR INCISIONAL BIOPSY SKIN SINGLE LESION 11106 $403.00 11107 PR INCISIONAL BIOPSY SKIN EA SEP/ADDITIONAL LESION 11107 $190.00 11200 PR REMOVAL OF SKIN TAGS, UP TO 15 11200 $235.00 11201 PR REMOVAL OF SKIN TAGS, EACH ADD 10 11201 $56.00 11300 PR SHAV SKIN LES <5MM TRUNK,ARM,LEG 11300 $265.00 11301 PR SHAV SKIN LES 6-10MM TRUNK,ARM,LEG 11301 $322.00 11302 PR SHAV SKIN LES 11-20MM TRUNK,ARM,LEG 11302 $372.00 11303 PR SHAV SKIN LES >21MM TRUNK,ARM,LEG 11303 $409.00 11305 PR SHAV SKIN LES <5MM REMAINDR BODY 11305 $279.00 11306 PR SHAV SKIN LES 6-10MM REMAINDR BODY 11306 $326.00 11307 PR SHAV SKIN LES 11-20MM REMAINDR BODY 11307 $381.00 11308 PR SHAV SKIN LES >21MM REMAINDR BODY 11308 $407.00 11310 PR SHAV SKIN LES <5MM FACE,FACIAL 11310 $307.00 11311 PR SHAV SKIN LES 6-10MM FACE,FACIAL 11311 $364.00 11312 PR SHAV SKIN LES 11-20MM FACE,FACIAL 11312 $420.00 11313 PR SHAV SKIN LES >21MM FACE,FACIAL 11313 $468.68 11400 PR EXC SKIN BENIG <5MM TRUNK,ARM,LEG 11400 $333.00 11401 PR EXC SKIN BENIG 0.6-1CM TRUNK,ARM,LEG 11401 $406.00 11402 PR EXC SKIN BENIG 1.1-2CM TRUNK,ARM,LEG 11402 $450.00 11403 PR EXC SKIN BENIG 2.1-3CM TRUNK,ARM,LEG 11403 $520.00 11404 PR EXC SKIN BENIG 3.1-4CM TRUNK,ARM,LEG 11404 $591.00 11406 PR EXC SKIN BENIG >4CM TRUNK,ARM,LEG 11406 $845.00
Load more

Recommended publications
  • Sa G Es 2 0 0 6 Sages Lunches
    TABLE OF CONTENTS 1 SAGES Corporate Supporters S 2 Hotel Contact Information THANKS TO OUR 2 General Information about the Meeting A 2 Registration Hours & Information CORPORATE SUPPORTERS: 2 Exhibits and Exhibit Only Registration G 5 SAGES Meeting Leaders PLATINUM LEVEL DONORS 7 SAGES Accreditation & CME Worksheet AUTOSUTURE & VALLEYLAB – E 8 Forde Tribute Dinner DIVISIONS OF TYCO HEALTHCARE 8 Hilton Anatole Floor Plan S 9 SAGES Schedule at a Glance ETHICON ENDO-SURGERY, INC. SAGES 2006 Postgraduate Courses 15 Bariatric Postgraduate Course KARL STORZ ENDOSCOPY-AMERICA, INC. 2 16 Joint SAGES-MIRA Symposium–Robotics 0 35 Colon Postgraduate Course OLYMPUS AMERICA 55 SAGES Allied Health Professionals Course GOLD LEVEL DONORS 0 SAGES 2006 Hands-On Courses 12 Joint IPEG/SAGES Pediatric Fellows Inamed Health 6 Advanced Techniques Hands-On Course Stryker Endoscopy 20 Surgeon in the Digital Age 27 Advanced Skills & Laparoscopic Techniques SILVER LEVEL DONORS Hands-On Course Boston Scientific Endoscopy 28 SAGES/SLS Simulator Hands-on Course Davol, Inc. 31 SAGES Endoluminal Surgery Hands-on Course General Surgery News 18 Joint SAGES/ACS Sessions Gore & Associates, Inc. 18 Inflammatory Bowel Disease 18 The Changing Face of Surgical Education BRONZE LEVEL DONORS 20 Ethicon Patient Safety Lunch Adolor Corporation and GlaxoSmithKline 22 International Video Session: Teleconferenced to Asia Aesculap 23 SAGES Technology Pavillion B-K Medical Systems 27 SAGES/IPEG Combined Video Breakfast Session Cook Surgical 32 SAGES/Fellowship Council Lunch 37 SAGES Hernia Symposium Medtronic 37 SAGES Bariatric Symposium SurgRX 39 SAGES 2006 Scientific Session Synovis Surgical Innovations 41 SAGES Presidential Address Taut, Inc. 43 Gerald Marks Lecture Tissue Science Laboratories 53 Karl Storz Lecture 44 SAGES/IPEG Panel, SAGES/ASGE Panel, Hernia Panel SAGES recognizes TATRC as a Meeting Supporter.
    [Show full text]
  • Clinical Practice Guideline for Limb Salvage Or Early Amputation
    Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline Adopted by: The American Academy of Orthopaedic Surgeons Board of Directors December 6, 2019 Endorsed by: Please cite this guideline as: American Academy of Orthopaedic Surgeons. Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline. https://www.aaos.org/globalassets/quality-and-practice-resources/dod/ lsa-cpg-final-draft-12-10-19.pdf Published December 6, 2019 View background material via the LSA CPG eAppendix Disclaimer This clinical practice guideline was developed by a physician volunteer clinical practice guideline development group based on a formal systematic review of the available scientific and clinical information and accepted approaches to treatment and/or diagnosis. This clinical practice guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s specific clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all individuals whose names appear as authors or contributors to this clinical practice guideline filed a disclosure statement as part of the submission process. All panel members provided full disclosure of potential conflicts of interest prior to voting on the recommendations contained within this clinical practice guideline. Funding Source This clinical practice guideline was funded exclusively through a research grant provided by the United States Department of Defense with no funding from outside commercial sources to support the development of this document.
    [Show full text]
  • Chapter 28 *Lecture Powepoint
    Chapter 28 *Lecture PowePoint The Female Reproductive System *See separate FlexArt PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Introduction • The female reproductive system is more complex than the male system because it serves more purposes – Produces and delivers gametes – Provides nutrition and safe harbor for fetal development – Gives birth – Nourishes infant • Female system is more cyclic, and the hormones are secreted in a more complex sequence than the relatively steady secretion in the male 28-2 Sexual Differentiation • The two sexes indistinguishable for first 8 to 10 weeks of development • Female reproductive tract develops from the paramesonephric ducts – Not because of the positive action of any hormone – Because of the absence of testosterone and müllerian-inhibiting factor (MIF) 28-3 Reproductive Anatomy • Expected Learning Outcomes – Describe the structure of the ovary – Trace the female reproductive tract and describe the gross anatomy and histology of each organ – Identify the ligaments that support the female reproductive organs – Describe the blood supply to the female reproductive tract – Identify the external genitalia of the female – Describe the structure of the nonlactating breast 28-4 Sexual Differentiation • Without testosterone: – Causes mesonephric ducts to degenerate – Genital tubercle becomes the glans clitoris – Urogenital folds become the labia minora – Labioscrotal folds
    [Show full text]
  • Otoplasty-Plastic Surgery of the Ears (Pdf)
    Vinod K. Anand, MD, FACS Nose and Sinus Clinic Plastic Surgery of the Ears (Otoplasty) This brochure will familiarize you with some basic facts about cosmetic surgery of the ear. It will give you enough general background to make you an "educated consumer." Your facial plastic surgeon will explain how this procedure applies to an individual's condition. A SOLUTION FOR A VERY COMMON PROBLEM The most common cosmetic problem that people have with their ears is that they pro- trude. Otoplasty is the name given to the operation designed to "pin back" the ears and to change their shape and contour. While otoplasty can be performed at any age after four or five years, it often is recom- mended in the preschool years to alleviate possible teasing at school by other children. DECIDING ON AN OPERATION Anyone interested in cosmetic surgery of the ear for himself or a child should consult a competent facial plastic surgeon. During the initial visit, the surgeon makes a thorough evaluation of the ears to determine whether surgery is indicated. The surgeon will then discuss any questions and concerns related to the surgery. In addition to the skill of the surgeon, the patient's realistic expectations about the results of the surgery and his general emotional state are important considerations. Mental attitude is as important as the ability to heal in evaluating candidates for facial plastic surgery. Once surgery is agreed upon, pre-operative photographs are taken to help the surgeon plan the operation. These photographs usually are compared with similar ones taken sometime after surgery and serve as a permanent before-and-after record of the results.
    [Show full text]
  • Chapter 24 Primary Sex Organs = Gonads Produce Gametes Secrete Hormones That Control Reproduction Secondary Sex Organs = Accessory Structures
    Anatomy Lecture Notes Chapter 24 primary sex organs = gonads produce gametes secrete hormones that control reproduction secondary sex organs = accessory structures Development and Differentiation A. gonads develop from mesoderm starting at week 5 gonadal ridges medial to kidneys germ cells migrate to gonadal ridges from yolk sac at week 7, if an XY embryo secretes SRY protein, the gonadal ridges begin developing into testes with seminiferous tubules the testes secrete androgens, which cause the mesonephric ducts to develop the testes secrete a hormone that causes the paramesonephric ducts to regress by week 8, in any fetus (XX or XY), if SRY protein has not been produced, the gondal ridges begin to develop into ovaries with ovarian follicles the lack of androgens causes the paramesonephric ducts to develop and the mesonephric ducts to regress B. accessory organs develop from embryonic duct systems mesonephric ducts / Wolffian ducts eventually become male accessory organs: epididymis, ductus deferens, ejaculatory duct paramesonephric ducts / Mullerian ducts eventually become female accessory organs: oviducts, uterus, superior vagina C. external genitalia are indeterminate until week 8 male female genital tubercle penis (glans, corpora cavernosa, clitoris (glans, corpora corpus spongiosum) cavernosa), vestibular bulb) urethral folds fuse to form penile urethra labia minora labioscrotal swellings fuse to form scrotum labia majora urogenital sinus urinary bladder, urethra, prostate, urinary bladder, urethra, seminal vesicles, bulbourethral inferior vagina, vestibular glands glands Strong/Fall 2008 Anatomy Lecture Notes Chapter 24 Male A. gonads = testes (singular = testis) located in scrotum 1. outer coverings a. tunica vaginalis =double layer of serous membrane that partially surrounds each testis; (figure 24.29) b.
    [Show full text]
  • Acute Limb Ischemia Secondary to Myositis- Induced Compartment Syndrome in a Patient with Human Immunodeficiency Virus Infection
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Acute limb ischemia secondary to myositis- induced compartment syndrome in a patient with human immunodeficiency virus infection Russell Lam, MD, Peter H. Lin, MD, Suresh Alankar, MD, Qizhi Yao, MD, PhD, Ruth L. Bush, MD, Changyi Chen, MD, PhD, and Alan B. Lumsden, MD, Houston, Tex Myositis, while uncommon, develops more frequently in patients with human immunodeficiency virus infection. We report a case of acute lower leg ischemia caused by myositis in such a patient. Urgent four-compartment fasciotomy of the lower leg was performed, which decompressed the compartmental hypertension and reversed the arterial ischemia. This case underscores the importance of recognizing compartment syndrome as a cause of acute limb ischemia. (J Vasc Surg 2003;37:1103-5.) Compartment syndrome results from elevated pressure compartment was firm and tender. Additional pertinent laboratory within an enclosed fascial space, which can occur after studies revealed creatine phosphokinase level of 53,350 U/L; fracture, soft tissue injury, or reperfusion after arterial isch- serum creatinine concentration had increased to 3.5 mg/dL, and emia.1 Other less common causes of compartment syn- WBC count had increased to 18,000 cells/mm3. Venous duplex drome include prolonged limb compression, burns, and scans showed no evidence of deep venous thrombosis in the right extreme exertion.1 Soft tissue infection in the form of lower leg. Pressure was measured in all four compartments of the myositis is a rare cause of compartment syndrome. We right calf and ranged from 55 to 65 mm Hg.
    [Show full text]
  • Large Animal Surgical Procedures As-Of December 1, 2020 Abdominal
    Large Animal Surgical Procedures as-of December 1, 2020 Core Curriculum Category Surgical Category Surgical Procedure Diaphragmatic herniorrhaphy Exploratory celiotomy - left flank Exploratory celiotomy - right flank Abdominal cavity/wall Exploratory celiotomy - ventral midline Exploratory celiotomy - ventral paramedian Exploratory laparotomy - death / euthanasia on table Peritoneal lavage via celiotomy Cecocolostomy Ileo-/Jejunocolostomy Cecum Jejunocecostomy Typhlectomy, partial Typhlotomy Abomasopexy, laparoscopic Abomasopexy, left flank Abdominal - LA Abomasopexy, paramedian Food animal GI: Abomasum Abomasotomy Omentopexy Pyloropexy, flank Reduction of volvulus Typhlectomy Food animal GI: Cecum Typhlotomy Food animal GI: Descending colon, Rectal prolapse, amputation/anastomosis rectum Rectal prolapse, submucosal reduction Food animal GI: Rumen Rumenotomy Decompression/emptying (no enterotomy) Food animal GI: Small intestine Enterotomy Reduction w/o resection (incarceration, volvulus, etc.) Resection/anastomosis Enterotomy Reduction of displacement Food animal GI: Spiral colon Reduction of volvulus Resection/anastomosis (inc. atresia coli) Side-side anastomosis, no resection Colopexy, hand-sutured Colopexy, laparoscopic Colostomy Large colon Enterotomy Reduction of displacement Reduction of volvulus Resection/anastomosis Biopsy Liver Cholelith removal Liver lobectomy Laceration repair Rectum Rectal prolapse repair Resection/anastomosis Enterotomy Impaction resolution via celiotomy Small colon Resection/anastomosis Taeniotomy Decompression/emptying
    [Show full text]
  • 1311 Diploma in Medical Record Science Second
    [LD 0212] AUGUST 2013 Sub. Code: 1311 DIPLOMA IN MEDICAL RECORD SCIENCE SECOND YEAR PAPER II – INTERNATIONAL CLASSIFICATION OF DISEASES (ICD-10) & SURGICAL PROCEDURES (ICM-9CM) Q.P. Code : 841311 Time : Three Hours Maximum : 100 marks Answer ALL questions I Write appropriate codes using ICD -10 (30 x 1 = 30) 1. Therapeutic introduction of hand tendon. 2. Excision of major partial thickness of eyelid excision. 3. Interphalangeal arthrodesis of Toe. 4. Division of percutaneous spinal cord nerve tracts. 5. Transfusion of allograft bone aetriosus. 6. Rastelli operation of truncus arteriosus. 7. Pyoloric sphincter dilatation. 8. Stapling of radius epiphyseal plate. 9. Suture of hands fascia. 10. Suture of hand fascia. 11. Repair of anterior wall (abdomen) hernia. 12. Foreign body removal without incision in t o the brain. 13. Repair of Tetrology of fallot. 14. Frontal Sinusectomy. 15. Urethral sling suspension. 16. Bone shaft transfer. 17. Coil of aneuryum repair. 18. Sling suspension. 19. Radio isotope scanning, pituitary gland. 20. Spinal shunt removal. 21. Acute lung edema. Due to external agent. 22. Proximal end tibial closed fracture was riding a two wheeler-slip & fell down. 23. Thrombosed internal hemorrhoids. 24. Secondary hypertension due to renal disorder. 25. Old myocardial infarction. 26. Fall from high place, injured elbow. 27. Chronic venous (peripheral) insufficiency. 28. Acute myeloid leukemia. 29. Post-operative intestine obstruction. 30. Abnormal pregnancy. II Writes appropriate codes using ICS-9CM (20 x 2 = 40) 1. Pregnant women suffering from acute salphingo oophoritis. 2. Accidental intake of ferrous salt. 3. Sprain of lumbar spine as stuck by another person. 4.
    [Show full text]
  • Colorectal Cancer Screening
    CLINICAL MEDICAL POLICY Policy Name: Colorectal Cancer Screening Policy Number: MP-059-MD-PA Responsible Department(s): Medical Management Provider Notice Date: 03/19/2021 Issue Date: 03/19/2021 Effective Date: 04/19/2021 Next Annual Review: 02/2022 Revision Date: 02/17/2021 Products: Gateway Health℠ Medicaid Application: All participating hospitals and providers Page Number(s): 1 of 10 DISCLAIMER Gateway Health℠ (Gateway) medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions. POLICY STATEMENT Gateway Health℠ may provide coverage under the medical-surgical benefits of the Company’s Medicaid products for medically necessary colorectal cancer screening procedures. This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records. (Current applicable Pennsylvania HealthChoices Agreement Section V. Program Requirements, B. Prior Authorization of Services, 1. General Prior Authorization Requirements.) Policy No. MP-059-MD-PA Page 1 of 10 DEFINITIONS Average-Risk Population – Patient population defined as having no personal history of adenomatous polyps, colorectal cancer, or inflammatory bowel disease (Crohn’s disease and Ulcerative Colitis); no family history of colorectal cancer or adenomatous polyps, familial adenomatous polyposis, or hereditary nonpolyposis colorectal cancer. High-Risk Population – Patient population defined as having a first-degree relative (sibling, parent, or child) who has had colorectal cancer or adenomatous polyps; OR family history of familial adenomatous polyposis; OR family history of hereditary non-polyposis colorectal cancer; OR family history of MYH- associated polyposis in siblings; OR diagnosis of Cowden syndrome.
    [Show full text]
  • The Posterior Muscles of the Auricle: Anatomy and Surgical Applications
    Central Annals of Otolaryngology and Rhinology Research Article *Corresponding author Christian Vacher, Department of Maxillofacial Surgery & Anatomy, University of Paris-Diderot, APHP, 100, The Posterior Muscles of the Boulevard Général Leclerc, 92110 Clichy, France, Tel: 0033140875671; Email: Submitted: 19 December 2014 Auricle: Anatomy and Surgical Accepted: 16 January 2015 Published: 19 January 2015 Applications Copyright © 2015 Vacher et al. Rivka Bendrihem1, Christian Vacher2* and Jacques Patrick Barbet3 OPEN ACCESS 1 Department of Dentistry, University of Paris-Descartes, France Keywords 2 Department of Maxillofacial Surgery & Anatomy, University of Paris-Diderot, France • Auricle 3 Department of Pathology and Cytology, University of Paris-Descartes, France • Anatomy • Prominent ears Abstract • Muscle Objective: Prominent ears are generally considered as primary cartilage deformities, but some authors consider that posterior auricular muscles malposition could play a role in the genesis of this malformation. Study design: Auricle dissections of 30 cadavers and histologic sections of 2 fetuses’ ears. Methods: Posterior area of the auricle has been dissected in 24 cadavers preserved with zinc chlorure and 6 fresh cadavers in order to describe the posterior muscles and fascias of the auricle. Posterior auricle muscles from 5 fresh adult cadavers have been performed and two fetal auricles (12 and 22 weeks of amenorhea) have been semi-serially sectioned in horizontal plans. Five µm-thick sections were processed for routine histology (H&E) or for immuno histochemistry using antibodies specific for the slow-twitch and fast-twich myosin heavy chains in order to determine which was the nature of these muscles. Results: The posterior auricular and the transversus auriculae muscles looked in most cases like skeletal muscles and they were made of 75% of slow muscular fibres.
    [Show full text]
  • The Reproductive System
    27 The Reproductive System PowerPoint® Lecture Presentations prepared by Steven Bassett Southeast Community College Lincoln, Nebraska © 2012 Pearson Education, Inc. Introduction • The reproductive system is designed to perpetuate the species • The male produces gametes called sperm cells • The female produces gametes called ova • The joining of a sperm cell and an ovum is fertilization • Fertilization results in the formation of a zygote © 2012 Pearson Education, Inc. Anatomy of the Male Reproductive System • Overview of the Male Reproductive System • Testis • Epididymis • Ductus deferens • Ejaculatory duct • Spongy urethra (penile urethra) • Seminal gland • Prostate gland • Bulbo-urethral gland © 2012 Pearson Education, Inc. Figure 27.1 The Male Reproductive System, Part I Pubic symphysis Ureter Urinary bladder Prostatic urethra Seminal gland Membranous urethra Rectum Corpus cavernosum Prostate gland Corpus spongiosum Spongy urethra Ejaculatory duct Ductus deferens Penis Bulbo-urethral gland Epididymis Anus Testis External urethral orifice Scrotum Sigmoid colon (cut) Rectum Internal urethral orifice Rectus abdominis Prostatic urethra Urinary bladder Prostate gland Pubic symphysis Bristle within ejaculatory duct Membranous urethra Penis Spongy urethra Spongy urethra within corpus spongiosum Bulbospongiosus muscle Corpus cavernosum Ductus deferens Epididymis Scrotum Testis © 2012 Pearson Education, Inc. Anatomy of the Male Reproductive System • The Testes • Testes hang inside a pouch called the scrotum, which is on the outside of the body
    [Show full text]
  • En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach Sanjay S Reddy1* and Norman D Bloom2
    Reddy and Bloom World Journal of Surgical Oncology 2012, 10:222 http://www.wjso.com/content/10/1/222 WORLD JOURNAL OF SURGICAL ONCOLOGY REVIEW Open Access En bloc resection of extra-peritoneal soft tissue neoplasms incorporating a type III internal hemipelvectomy: a novel approach Sanjay S Reddy1* and Norman D Bloom2 Abstract Background: A type III hemipelvectomy has been utilized for the resection of tumors arising from the superior or inferior pubic rami. Methods: In eight patients, we incorporated a type III internal hemipelvectomy to achieve an en bloc R0 resection for tumors extending through the obturator foramen or into the ischiorectal fossa. The pelvic ring was reconstructed utilizing marlex mesh. This allowed for pelvic stability and abdominal wall reconstruction with obliteration of the obturator space to prevent herniations. Results: All eight patients had an R0 resection with an overall survival of 88% and with average follow up of 9.5 years. Functional evaluation utilizing the Enneking classification system, which evaluates motion, pain, stability and strength of the affected extremity, revealed a 62% excellent result and a 37% good result. No significant complications were associated with the operative procedure. Marlex mesh reconstruction provided pelvic stability and eliminated all hernial defects. Conclusion: The superior and inferior pubic rami provide a barrier to a resection for tumors that arise in the extra-peritoneal pelvis extending through the obturator foramen or ischiorectal fossa. Incorporating a type III internal
    [Show full text]